Search - tctmd.com

Displaying 501 - 520 of 900

Sort: Relevancy | Date

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Daily News

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

Todd Neale

April 10, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

Presentation ACC 2017

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

Presenter: Pieter Smits

March 20, 2017

Presentation ACC 2017

iFR vs FFR for Guiding Coronary Revascularization – DEFINE-FLAIR

Presenter: Justin E Davies

March 19, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News ACC 2017

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

L.A. McKeown

March 09, 2017

News Daily News

Deserved or Not, Public Reports on Underperforming PCI Hospitals Improves Performance

Yael L. Maxwell

March 07, 2017

News Daily News

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

Caitlin E. Cox

March 07, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

Rate of Incomplete Revascularization During PCI Is Highly Variable Across Operators

Todd Neale

February 15, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Michael O'Riordan

February 03, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

Noncardiac Surgery Riskier After Incomplete vs Complete Revascularization, Observational Study Finds

Yael L. Maxwell

February 01, 2017

Advertisement

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

iFR vs FFR for Guiding Coronary Revascularization – DEFINE-FLAIR

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

Deserved or Not, Public Reports on Underperforming PCI Hospitals Improves Performance

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Rate of Incomplete Revascularization During PCI Is Highly Variable Across Operators

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Noncardiac Surgery Riskier After Incomplete vs Complete Revascularization, Observational Study Finds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content